Prof. Chun-Sing Lee obtained his BSc and PhD degrees from the University of Hong Kong in 1987 and 1991 respectively. He then furthered his research career at the University of Birmingham of UK with the support oftheCroucher Foundation Fellowship. Prof. Lee joined City University of Hong Kong in 1994 and is currently a Chair Professor of Materials Chemistry and the Dean of College of Science. He also co-founded the Center Of Super-Diamond and Advanced Films (COSDAF) in 1998 and served as the Center’s Director/ Deputy Director till 2022. Prof. Lee’s current research interests include organic electronic devices and nanomaterials for energy, environmental and biomedical applications. In 2016, he established the journal Materials Today Energy with Elsevier and served as the Editor-in-Chief. Prof. Lee has published about 900 journal papers with over 40,000 citations and a Scopus/WoSh-index of over 110.

Prof. Cohn’s research activities focus on the synthesis, characterization and biological interactions of implantable polymeric biomaterials and the engineering of medical devices, with special emphasis on the following areas: Biomedical polymers, Biodegradable polymers, 3D printed biomedical systems. He has published numerous scientific papers, holds many patents (more than ten have been commercialized), edited several books and organized many international scientific conferences. He has served as the Director of the Casali Center of Applied Chemistry and as the Head of the School of Chemistry of the Hebrew University of Jerusalem. Has been a key player in various start-up companies and has collaborative projects with leading Companies in the Medical Devices field, mainly in the US and Europe, based on technologies developed in his lab. Two products based on biodegradable polymers developed in his laboratory have been approved for clinical use by the FDA and other leading regulatory agencies. A third product based on a polymer developed in his laboratory has received the CE mark. Several additional polymeric medical devices developed in Prof. Cohn’s laboratory are at various stages of their industrial development and regulatory process.

Will be Updated Soon

Paulo C. DE MORAIS, PhD, was full Professor of Physics at the University of Brasilia (UnB) – Brazil up to 2013, Appointed as UnB’s Emeritus Professor (2014), Appointed as Guest Professor of Huazhong University of Science and Technology– China (2011), Visiting Professor at Huazhong University of Science and Technology (HUST) – China (2012-2015), Appointed as Distinguished Professor at Anhui University (AHU) – China (2016-2019), Appointed as Full Professor at Catholic University of Brasília (UCB) – Brazil (2018), Appointed as CNPq-1A Research Fellowship since 2010, 2007 Master Research Prize from UnB, 2008-member of the European ERA NET Nanoscience Committee, Member of the IEEE-Magnetic Society Technical Committee, Senior Member of the IEEE Society, 2012 China’s 1000 Foreign Expert Recipient, and 2012 Academic Excellence Award from Brazilian Professor’s Union. He held two-years (1987-1988) post-doc position with Bell Communications Research – New Jersey, USA and received his Doctoral degree in Solid State Physics (1986) from the Federal University of Minas Gerais – Brazil. He graduated in both Chemistry (1976) and Physics (1977) at UnB.ProfessorMorais is member of the Brazilian Physical Society and the Institute of Electrical and Electronics Engineers – IEEE. He has served as referee for more than 50 technical journals, takes part of the Editorial Board of more than 15 technical journals and has conducted research on nanomaterials for over 40 years. He has delivered more than 150 Invited Talks all over the World. He is known for his research in preparation, characterization and applications of nanosized materials (magnetic fluid, magnetoliposome, magnetic nanoemulsion, magnetic nanocapsule, magnetic nanofilm, magnetic nanocomposite, nanosized semiconductors, polymeric dots, carbon dots, graphene quantum dots, and nanosilica). With more than 450 published papers in peer reviewed journals, he has appeared in recent World ranking of top 1% scientists, such as 2020-Stanford and 2022-Research.com

Yoshikazu Ohya is a microbiologist and doctor in biological sciences from the University of Tokyo. During the first years of his career, he graduated from the University of Tokyo and then moved to Stanford University. After working with David Botstein, he moved back to the University of Tokyo. His research interest is in fundamental theories and concepts of eukaryotic cells and their applications. For this purpose, he used the budding yeast Saccharomyces cerevisiae as a model organism, using bioimaging technology and cell biology techniques. Multivariate analysis with morphological data provided high-dimensional phenotypic information of all individual mutant strains of the budding yeast. Comprehensive analysis of mutant strains revealed new genetic dogmas, discovered close relationships between gene function and morphological phenotype, elucidated new gene functions, and classified mutant strains by clustering based on morphological information. He has also conducted target prediction and identification of compounds.

Professor Sabu Thomas is currently Vice Chancellor of Mahatma Gandhi University, Kottayam, Kerala, india. Prof.Thomas is a highly committed teacher and a remarkably active researcher well-known nationally and internationally for his outstanding contributions in polymer science and nanotechnology. He has published over 1200 research articles in international refereed journals. and has also edited and written 140 books with an H-index of 106 and total citation of more than 53,000. He has received a large number of international and national awards and recognitions. Under the leadership of Prof. Thomas, Mahatma Gandhi University has been transformed into a top University in the country where excellent outcome-based education is imparted to the students for their holistic development.

Dr. Gerald Lushington is a veteran biomolecular scientist specializing in neuroimmunology and toxicology research, using collaborative methods in information science, informatics and computational technology. Lushington’s biotech development foci span the horizon from clinical analytics and trial refinement to the development of novel therapeutics and diagnostics for chronic immune, metabolic and neurological conditions, with a heavy focus on the hidden roles of pathologically modified proteins Lushington has five biotechnology patents, 230+ scientific publications, roughly 5400 citations and a h-index of 42. He is a co-founder and Chief Scientific Officer of Qnapsyn Biosciences, Inc., and also serves as Editor in Chief of Combinatorial Chemistry & High Throughput Screening (Bentham), and Courtesy Professor of Food, Nutrition, Dietetics and Health at Kansas State University.

Ekaterina Kolesova is a Researcher of Translation Medicine Scientific Center (Sirius University, Russia). She completed her PhD degree in Optics at the ITMO University in 2019. After accomplishing her post-doctoral studies in hybrid structures formation for biomedical application, she worked 2 years at ITMO University as an Associate Professor and supervised the work of bachelor and master students. She works in laboratory of Molecular Nanomedicine, since 2022. Her current research involves nanomaterials synthesis and investigation of its potential effect on cell metabolism and application as nanocarrier for drug delivery in cancer therapy. Dr. Kolesova was a winner of Ostrogradsky Fellowship (Embassy of France in Russia) and worked in ENS de Lyon. She is the head of2 grants for young scientists, and the executor of 5 scientific projects. Dr. Kolesova has 2 patents and author more than 25 articles indexed in WoS/Scopus.

Project "Application of antisense oligonucleotides as antibacterial agents in Enterococcus faecalis", Funding institution SRF SU, 2020 to 2020, rewarded for the most successful project in the field of Biological Sciences and presented at the Sofia Science Festival. First prize for most successful young microbiologist in Bulgaria by “Prof. Dr. Stefan Angelov” Foundation for the work published in article: Targeting TPP riboswitches using chimeric antisense oligonucleotide technology for antibacterial drug development“, ACS Applied Bio Materials, 2022,

Kazuko Matsumoto was born in Tokyo, Japan. She was educated at Department of Chemistry, The University of Tokyo for B. S. in 1972, M. S. in 1974, and PhD in 1977. She joined the same department as research associate in 1977, then moved in 1984 to Department of Chemistry, Waseda University in Tokyo as associate professor, where she was promoted to a full professor in 1989. During these years, she spent several short periods as visiting scholar or visiting professor at MIT, USA, Institute of Molecular Science, Japan, and several major universities in Japan. During 2002-2005 she served as a member of The Council of Science and Technology Policy (Cabinet Office of Japanese Government). Her major research area is metal coordination chemistry and bioanalytical chemistry, more specifically; (i) development of lanthanide complexes as luminescent bio- labels for time-resolved detection in immunoassay, bio-imaging, and microarray. (ii) linear Pt chain complexes having Pt-Pt-Pt multiple bonds as spin and electro-conducting materials. (iii) development of nanodiamond as bio-molecule or spin carrier nano-particles. Since 2012, she has been a director of Honda Foundation and contributing to promotion of young scientists and engineers in Asian countries, and also to honoring excellent scientific and engineering achievements in the world by awarding Honda Prize.

Dr. Samia Aboushoushah is an associate professor and medical physicist in the Department of Physics, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia. She obtained her PhD degree from Sir Peter Mansfield Magnetic Resonance Imaging Centre, Nottingham University, United Kingdom in 2011. Her research interests include developing Magnetic Resonance Imaging (MRI) methods for medical applications and developing Functional Magnetic Resonance Imaging (fMRI) techniques to investigate the human brain. She has served as Supervisor of the Department of Physics Ladies Section from 2012-2016. Samia translated the book “MRI: the Basics” Third Edition by Ray Hashman Hashemi, William G. Badley Jr, and Christopher J. Lisanti into Arabic. Samia has been researching nano-materials compatible in the MRI environment and has studied their medical applications as contrast agents in MRI and drug delivery systems. Currently, Samia has directed her research towards the synthesis and characterization of biocompatible and nontoxic nano-materials for various medical applications.

Abdul-Rhman has completed his master degree from cairo University and work as a speacialist at agricultural microbiology department at national research center and research assistant ship at at Environmental Biotechnology Department, Genetic Engineering and Biotechnology Research Institute (GEBRI), Scientific Research and Technological Applications City (SRTA-City).He has published paper in biocatalysis and agricultural biotechnology journal (Q1) junder titile Studying the behavior of the light-off bioreporter DF4/PUTK2 as a light-on assay against lead, He received the Next Generation Scholars Scholarship, which is granted to outstanding students and top university graduates to study for a master's degree, lecturer at summer school of biotechnology, city for scientific research and technology applications from march 2018 to march 2019, Scientific manager spirulina project at Nobaria (2015-2018), Speaker at the 23rd Global Biotechnology Congress London, UK., Speaker at 10th international conference on food science and food safety & 24th Global Biotechnology Congress, Middlesex University, UK, invited speaker at 2nd Global Summit and Expo on Biotechnology and Bioscience (GSEBB2022).

This presentation reports on the development of a fixed bed pervious concrete Anaerobic Digestion (AD) process, a patent that has been provisionally registered in South Africa. The anaerobic digester was primarily developed for lower operational cost biological sulphate reduction for the bioremediation of Acid Mine Drainage (AMD) and effluent streams to produce biogas and treated wastewaters. This talks presents the initial design and capabilities of a fixed bed pervious concrete anaerobic digester for bioremediation particularly applicable to AMD remediation and may also be purposed for municipal effluent and industrial effluent treatment such as sewage treatment. In one embodiment, the fixed bed pervious concrete anaerobic digester for bioremediation process comprising of an enclosure or vessel (herein referred to as the reactor) with pervious concrete moulds positioned within it, a recycling system to circulate the effluent, an influent dispersion system and a biogas outlet to release the gas generated during operation. In another embodiment the reactor volume is configured such that the effluent does not require recycling to achieve the required Hydraulic Retention Time (HRT) and therefore does not have a recycling system. This address reports on the invention that has been provisionally registered under Section 30 (1) – Regulation 22 of the South African Patent Act of o 1978.

Prof. Howard E. Gendelman (born March 18, 1954) is an American physician-scientist whose research intersects the disciplines of neuroimmunology, pharmacology, and infectious diseases. Gendelman was born in Philadelphia, Pennsylvania. He is renowned for his research in harnessing immune responses for therapeutic gain in HIV/AIDS and Neurodegenerative disease. He is an author, editor, educator, and mentor. Since 2004, he has held the position of Margaret R. Larson Professor of infectious diseases and internal medicine at the University of Nebraska Medical Center (UNMC) in Omaha. He is the founding chair of the Department of Pharmacology and Experimental Neuroscience, director of the Center for Neurodegenerative Disorders, and the head of the Carol Swarts MD Neuroscience Laboratory. Gendelman possesses an H-index of 113,[2] authored more than 550 peer-reviewed publications, edited 17 books and monographs, is the recipient of numerous national and international research and mentoring awards, and holds 38 patents. He was the founding editor-in-chief of the Journal of Neuroimmune Pharmacology[3] (2004–2021) and currently leads the journal NeuroImmune Pharmacology and Therapeutics[4] (2022–present). Gendelman's group was among the first to reverse HIV-dementia in an infected person using combination antiretroviral therapy (ART), and they developed scores of rodent models to mimic HIV/AIDS end-organ disease.[12][13][14] He coined the term long-acting slow effective release ART (LASER ART). These works led to polymer discovery, targeted drug delivery to viral reservoirs, and reduction of residual virus in lymphoid organs. His research group was also the first to combine HIV reservoir-targeted LASER ART and CRISPR-Cas9 to eliminate chronic viral infection from infected animals. This curative approach (published in Nature Communications, 2019) received considerable attention in establishing a novel translational pathway for HIV eradication. This work followed the first ultra-long acting nanocrystal prodrug and the world's first HIV vaccine mimetic[18][19] (in Nature Materials, 2020). His work with cell-based drug delivery born out of nanoparticle-mononuclear phagocyte interactions has inspired broad pharmaceutical interest; in turn, Gendelman led the establishment of the Nebraska Nanomedicine Production Plant,[20]a biotechnology good manufacturing practices (cGMP) initiative, to position research for clinical translation in the development of long acting nanoformulated ART at UNMC. He also co-founded Exavir Therapeutics, Inc., a biotechnology company developing therapies towards and cure for HIV/AIDS.

Alain is a visionary and scientific thinker seemingly ahead of his time—exploring the edges, pioneering breakthroughs in multiple domains, even creating new fields of practice. Now he is weaving it all together to help society come together like never before, to help lead us to a better future. Starting off in Artificial Intelligence through his undergraduate studies, early work life, and graduate studies at Yale, Alain was on the development team that pioneered the first Knowledge Engineering Environment (KEE). Alain continued to expand his knowledge at Price Waterhouse, delivering complex information technology solutions for clients. After discovering the deep wealth of knowledge in improvisation, Alain engaged practitioners across the world to found the field of Applied Improvisation. Founding and leading Creative Advantage, an innovation consultancy firm, Alain added facilitation, creativity, and innovation skills to become a breakthrough innovation specialist. Birthing programs for executive and leadership teams globally in the public and private sectors, Alain served > 30 of the Fortune 500, including Bristol-Myers, Merck, Humana, Kraft, Starbucks, General Mills, General Electric, Saint-Gobain, Bank of America, and Intel. In 2016, Alain discovered how to articulate the healing power of our internal voice of unconditional love, bottling it in a self-guided meditation app, LOVEx.com. In 2018, with science-based sustainability solutions urgently needed, Alain started Clean Research, a non-profit designed to approach sustainability opportunity areas from a collaborative knowledge-building perspective from the start of the process. Leading 9 experts with > 30 scientists contributing complementary knowledge across organizational boundaries, Alain senior-authored a peer-reviewed scientific paper (2020), “A More Open Approach Is Needed to Develop Cell-Based Fish Technology.” The work, commissioned by One Earth, a top-tier sustainability science journal from Cell Press, demonstrates the value of truth-telling and collaboration in tackling our grand sustainability challenges. In the process of working closely with the very knowledgeable editorial team of One Earth, Alain came to learn that our grand challenges aren’t being addressed correctly at all. For one, they require fully transdisciplinary approaches, engaging the participation from many different types of experts with relevant knowledge from the start of the problem-solving process. Since today’s systems for advancing science, technology, and innovation do not support an ideal, speed-focused, virtually boundless, and knowledge-based approach, Alain blueprinted a new system for accelerating innovation. An 18-month facilitated innovation process is poised to deliver deep knowledge, breakthrough insights, and high value into multiple transdisciplinary challenge spaces such as carbon sequestration and grid-energy storage. With everything at stake, we win together. KEY EXPERTISE AREAS • Collaborative discovery of knowledge and insights for breakthrough innovation • Leadership, facilitation, collaboration, and co-creation • Navigating the unknown and improvisation • Systems integration, software engineering, and scale-up • Whole-systems thinking • Whole-systems thinking

Zhimei Du, MD/PhD, VP at Landmark Bio. Zhimei graduated from Cornell University Medical College – Memorial Sloan Kettering Cancer Center Joint Immunology Program. After graduation, she joined Robert G. Roeder’s laboratory at The Rockefeller University, exploring the genetic/epigenetic regulation mechanisms during leukemia genesis. She started her industrial career at Regeneron as protein engineer for bi-specific antibodies. Later, she joined Amgen followed by Teva Pharmaceuticals focusing on bioprocess development of biotherapeutics manufacturing. Zhimei had extensive experience in cell/gene therapy. She led cell/gene therapy clinical programs for type I diabetes at Diabetes Research Institute, U. of Miami. Zhimei joined Merck & Co. where she served as the Executive Director & Global Head of Process Cell Sciences, leading Process Cell Sciences Department, including allogeneic CAR-T and CAR-NK cell therapy process development, cell line development, cell banking, genetic/cytogenetic characterization, biomarker and predictive modeling. Later, she joined Atara Bio, a leading Allogeneic Cell/gene therapy company, as VP of Process & Analytics. Currently Zhimei is the Head of Research & Early Development at Landmark Bio, an innovative Cell/Gene Therapy Platform company. Zhimei is also the sponsor and core member of multiple Industrial-wide Consortium teams, setting up road map and establishing industrial common practices in various biotherapeutics development areas, including ISPE ATMP, Allogeneic Accelerated Development Network, BioPhorum Cell/Gene therapy, ADC/Bispeicifics Roadmap team co-lead at BPOD/NIMBLE, IQ comparability team, IQ sequence variant consortium team, IQ Design Space team

Associate Professor with Habilitationat Instituto Superior Técnico (IST), Lisbon University, Portugal. PhD in Civil Engineering by IST, in 2009 with the thesis Hydro-mechanical Behaviour of Compacted Marls (Manuel Rocha Award 2013) under the supervision of Prof E.Maranha das Neves (IST, Lisbon, Portugal) and Prof E. E. Alonso (UPC, Barcelona, Spain). Advanced MSc in Structural Engineering in 2003 with the thesis Seismic Behaviour of "Pombalino" Old Masonry Buildings(MOP Award 2005) (IST, Lisbon). Habilitation by Lisbon University in 2019 defending the work Micromechanical Analysis of Artificially Cemented Sandy Soils. Has 28 papers in international ISI/Scopus journals, 6 book chapters in international publications and more than 50 international conference papers (Scopus h_index=14). Invited for 16lectures (4 national and 12international). PI of 3 National Research Projects (2 ongoing) and member of several national research projects. Participation in several consultancy projects for companies. Responsible for 6 Advanced Training courses forPortuguese Civil Engineers. Member of the editorial Board of Transportation Geotechnics and of the reviewer board of Engineering Geology, both ISI journals, and of the editorial board of Soils and Rocks.Reviewer for several ISI journals and European projects. Member of scientific committees of several international conferences. Portuguese representative of the Technical Committee TC106 - Unsaturated Soils - of the ISSMFE. Supervisor of 7 PhD theses (3 ongoing) and more than 40 MSc theses (2 ongoing). Main research interests are focused on Biocementation and on the Electro-Chemo-Hydro-Mechanical behaviour of clays and structured materials considering their degree of saturation, including constitutive modeling of natural and artificially cemented geomaterials and how it is affected by structure loss caused by stress and suction cycles. Past work includes the numerical simulation of soil-atmosphere interaction considering the unsaturated behaviour of soils and the development of soil suction sensors for laboratory tests.

Roberta Bussamara is graduated in Chemical Engineering. She completed her PhD degree in Cellular and Molecular Biology at the Federal University of Rio Grande do Sul (UFRGS), southern Brazil in 2009. After accomplishing her post-doctoral studies in nanoparticle synthesis for enzyme immobilization, she worked 2 years at State University of Rio Grande do Sul (UERGS) as a Professor in the Biotechnology Department. In 2015, Dr. Bussamara was pointed as Professor of Bioinorganic Chemistry at Federal University of Rio Grande do Sul. She is head of the Laboratory of Proteins and Microorganisms Applied to Chemistry, since 2019. She worked as a Visiting Research at the University of Illinois in Chicago (USA), being responsible for green synthesis of new nanomaterials (2020). She was a Director of Scientific and Technologic Park of UFRGS from 2020 to 2022. Her current research involves nanomaterials synthesis and the use of proteins mainly enzymes in different applications.She has ten years’ experience in supervising students and researches in the area of Biotechnology, also patents issued and scientific articles involving proteins, microorganism and nanomaterials

RM was born in Sofia, Bulgaria in 1930. His father was a physician and head of the Jewish hospital in Sofia. RM went to an American Grade School in Sofia for 4 years until it was closed by the pro-German government. From 1942, for over 2 years –during the 2nd world war - his family lived in small villages in the Balkans. His parents believed that the family is safer there. Nevertheless his father was taken to a concentration camp for part of this time. RM immigrated to Israel in 1949. He studied biochemistry at the Hebrew University in Jerusalem (M.Sc.)and the Weizmann Institute in Rehovot (Ph.D.) He spent a year in New York, at the Rockefeller Institute and returned to the Weizmann Institute in 1960. He worked on the chemistry of various natural products. He initiated his work on hashish, which he received from the Police. In 1966 he moved to the Hebrew University, where he became a full professor in 1972. From 1979 to 1982 he was Rector (Academic Head) of the Hebrew University. He retired in 2000 but continued his research. He still has a lab with 3-4 post-doctoral researchers. His work has been mostly on the chemistry of natural products, the best known being on cannabinoids. In collaboration with numerous colleagues in Israel and abroad he has also published in pharmacology and on clinical trials. He has published about 470 scientific papers and has received numerous national and international prizes, including the Israel Prize – the most prestigious Israeli Prize – as well as a prize from the US National Institutes of Health. He is a member of the Israel Academy of Sciences, where he headed the Natural Sciences section from 2007 to 2013. He married Dalia (born Borovitch) in 1955 and they have 3 children, Roy, a professor of mathematics at the Technion in Haifa, Hadas, an M.D. ophtalmologist and Dafna, an M.D. pediatric neurologist. He has 7 grandchildren.

Dr. Rajwali Khan earned a DVM degree from Sind Agriculture University Tando Jam and obtained an M.Sc (Hons) degree from The University of Agriculture Peshawar-Pakistan (2008 and 2011). Dr. Khan joinedthe Livestock & Dairy Development Department (Research Wing) Government of KP Peshawar as Research Officer and performed dynamic duties in various positions in the area of Animal and Veterinary Science. He secured a lecturer position in 2014 at The University of Agriculture Peshawar-Pakistan. In 2016, Dr. Khan achieved a Chinese government Scholarship and obtained Ph. D degree in the field of Animal Breeding, Genetics, and Reproduction from Northwest Agriculture and Forestry University, China. Due to his excellent research and academic performance Dr. Khan was awarded a presidential award with a certificate and cash prize by the Chinese government. Currently, He is working as Assistant Professor at the University of Agriculture Peshawar-Pakistan. The key area of Dr. Khan research is genetic regulation of meat quality and production traits and transgenic animal production. Dr. Khan won three projects funded by government of Khyber Pakhtunkhwa and Higher education commission Pakistan. One project is in approval stage from Pakistan Science Foundation. Dr. Khan published more than 80 research and review articles in reputed journals with a cumulative impact factor of more than 250 (web of science). Dr. Khan published two books and extending editorial services to various journals such as Frontiers in Genetics, Frontiers in Veterinary Sciences, and Frontiers in Animal Sciences. Dr. Khan reviewed more than 60 articles for various reputed journals of Springer-nature, Elsevier, Oxford, Willey, MDPI, Frontiers, and Taylor and Francis group.

Dr.A.Haiter Lenin is a professor at WOLLO University in Ethiopia. He has completed his PhD from Anna University, Chennai. He also worked as a Head of the Department at PET Engg College. His mainly focus on the research areas of Thermal Engineering, Thermodynamics, Heat Transfer, Gas dynamics and Jet Propulsion, Alternative Fuels etc. He has membership in many Professional Bodies.

Dr Tarek Mohamed Kamal Mohamed Metawie, Professor of Biochemistry, Faculty of Pharmacy, Cairo University. Egyptian, date of birth 6/3/1955. Ph.D. in Pharmaceutical Sciences, 1984; M.Sc. in Pharmaceutical Sciences, 1979; B.Sc. in Pharmaceutical Sciences, Faculty of Pharmacy, Cairo University, 1976. Professional experience: Instructor; 1976, Lecturer Assistant; 1980, Lecturer, 1984; Assistant Professor, 1989; Professor,1994; Head of the Department of Biochemistry, Faculty of Pharmacy, Cairo:- 2008-2014.

Fasih Bintang Ilhami, Ph.D is currently a assistant professor at the State University of Surabaya, in Indonesia. His research interest is exploring selfassembled supramolecular nanoparticle for biomedical application. Specifically, his ongoing research employs water-soluble metallosupramolecular nanoparticle for chemotherapy without requiring incorporation of anticancer drugs. He earned his Ph.D. in 2020 from National Taiwan University of Science and Technology (NTUST), Taiwan. He conducted much of his research as an exchange Ph.D. student in the supramolecular nanoparticle. Afterward, he did postdoctoral work on supramolecular chemistry at NTUST 2021. Moreover, he continued his postdoctoral work at Academia Sinica, Taiwan 2022. In October 2022, he joined the State University of Surabaya as assistant professor

I have done my Doctorate at Dr. Harisingh Gour University, Sagar, Madhya Pradesh, India in the area of Plant Biotechnology and nanotechnology. Currently, I am working as an Assistant Professor in the Department of Biotechnology at Swami Vivekanand University, Sagar engaging in teaching activities for undergraduate and graduate students of Biotechnology. In my doctoral research, I have been working on the interaction of nanoparticles with potato plants to develop an efficient nanofertilizer for potato tuber yield. For this study, I have synthesized the nanoparticles (Ag, Fe and Mn) via using different plant extracts and to analyze their potential as nano-nutrients to increase the potato tuber yield and have expertise in operating and analyzing various modern cutting-edge techniques such as FTIR, XRD, Raman spectroscopy, SEM-EDX, and TEM microscopy, PCR, qPCR, RT-PCR, western blotting, agarose, and Polyacrylamide Gel electrophoresis, I have expertise in plant tissue culture, microbiology, nanotechnology, plant molecular biology most importantly in synthesis biocompatible of nanoparticles and its role in as an antimicrobial, catalytic and nano nutrients under in vitro condition. My research work has been published in some good international journals like Biocatalysis and Agriculture Biotechnology (2022), Bionanoscience (2019), and Sol-Gel Science and Technology (2018) and Plant Science today Journal (2020). I have been a recipient of the CSIR Foreign Travel Grants Award from Council of Scientific and Industrial Research for attending Applied Nanotechnology and nanoscience international Conference (ANNIC-2019) France and Awarded by the fellowship for the training of Young Scientist M.P. Council of Science and Technology, Bhopal in the year of 2020/2022. I have been also awarded by the prize in the national and international conference for best oral presentation.

Surabhi Sonam is an Associate Professor at D Y Patil International University, India and works on Biophysics and Mechanobiology. She did her postdoctoral research at Institue Jacques Monod, Paris on calculating the intercellular forces at multi-molecular scale and also to understand their effect in epithelial monolayers. During her PhD at Mechanobiology Institute, National University Singapore, she developed a microfluidics based platform embedded with nanoarchitectures and studied the effect of fluid shear stress on stem cell contractility and their fate. Her research work has been published in Nature Publishing Group and she now diversifies to work on prosthetics and brain computer interface as well.

Dr. NehaBajwais presently working as Assistant Professor at University Institute of Pharma Sciences, Chandigarh University, Mohali. She has more than 25 publications in international and national journals with total impact factor 126 including article in Nature materials and Advanced Drug Delivery Reviews. In addition she has been frequent writer at various magazines and newspapers. Presently, she won Young Investigator Training Program to work in University of Turin for six months. She also won travel grant from FIP to attend FIP-PSWC 2020 conference at Montreal, Canada. Currently, she is also Fellow/ Life member of Indian Pharmacy Graduate Associations and the Association of Pharmaceutical Teachers of India.She had attended and presented research papers in more than 20 national and international conferences. She won various best poster research award including 6th world congress on Nanomedical Sciences-ISNSCON-2018 held at VigyanBhawan, New-Delhi. During her Ph.D. she has worked on ICMR sponsored project entitled “Molecular Encapsulation Augmented Oral Delivery of Arteether: Formulation Design using Total Quality Management Approach”. Also she has worked on various govt. agencies like AICTE, UGC, DST, CYCLONET, FIP sponsored projects.

Dr. Umesh Kumar completed his Ph.D. in 2010 from University of Delhi, Delhi. He joined Deshbandhu College, University of Delhi as Assistant Professor in February 2011 and currently working as senior level. Dr. Kumar’s research interest is in the area of Coordination Chemistry, Bioinorganic Chemistry and Catalysis. He is recipient of ‘Fast Track Young Scientist’ and ‘Teachers Association for Research Excellence’ award from Science and Engineering Research Board (SERB), Department of Science and Technology, New Delhi, India. He has published several research articles in journals of American Chemical Society (ACS), Royal Society of Chemistry (RSC) and Elsevier etc. He also executed research projects funded by SERB, UGC and University of Delhi, India.

The author was born in 1958 in Towkok, Sonari, Cheraideo District, Assam, India. His parents were Powal Chandra Konwar and Dharmeswari Konwari. Hedid M Sc Agri in Plant Breeding and Genetics in 1983. In 1984, he joined AAU as Lecturer and in the next year became Assistant Professor. He took DIC (Micro) from Imperial College of Sci, Tech and Medicine, London, and Ph D (Pl Biotech) from University of London in 1992. Returning to India, he joined back AAU and became Associate Professor in 1994. In the next year, he joined Tocklai Experimental Station, TRA, Jorhat as a Senior Scientist (Biotechnology) at the age of 36 years, became In-charge and Head in 1999. In 2002, he joined Tezpur University, Assamas Professor and HoD of Mol Biol and Biotechnology; also Centre for Petroleum Biotechnology project and 2008 became Dean, School of Sci. and Tech. He successfully transferred the technology for ‘Bioremediation of petroleum contaminated field soil” to ONGC. In 2009, he established the Centre for Petroleum Biotechnology at Tezpur University on permanent basis. On 7th Sept 2011, he became Vice-Chancellor of Nagaland University (Central) and completed the term 7thSeptember2016and becameSenior Professor of Tezpur University in Nov 2018. He completed 12 National level research projects, guided 47M Sc and 15 Ph D students (6 ongoing). He filed 03 patents, deposited 11 gene sequences. He has 240 Assamese articles in magazines and newspapers, 50 popular English Science articles in national level magazines, 8 books by International/National/Regional Pub Agencies, 3 booklets, 21 book chapters, 149 research papers in International (Imp factor 1-7) journals, 71 conference proceedings, 91Conference presentation (abstracts) and 18Awards/Honors.

Prof Shaon Ray Chaudhuri did her PhD from Calcutta University in 2001 in Molecular Biology. She did her postdoctoral work at Technical University of Munich and Humboldt University. Her group has been working on Microbial Technology, with 12 students having received their PhD degree under her guidance. She has to her credit 5 technologies transferred, 5 awarded international patents, 4 granted Indian patents while 5 filed Indian patents. Two of the developed technologies have being tested in three industries in India. Her wastewater treatment technologies have won different awards like DST Lockheed Martin Indian Innovation Growth Program award in 2014, another won the President’s (of Republic of India) award under Technology category in 2019, NASI-Reliance Industries Platinum Jubilee Award for application oriented innovations in Biological Sciences 2020. She has formed the first startup of Tripura University named Waste to Wealth Innovative Technologies LLP with BIRAC funding. She has 64 papers and 22 book chapters to her credit.

Vidya Sankarapandian is an Associate Professor and Head of laboratories in the department of Microbiology and Immunology at Kampala international university, Uganda. She completed PhD in Microbiology in the year 2019 in the field of oral cancer. She has published more than 20 articles and 2 book chapters in peer reviewed journals. She has received the best young faculty award from global eminence award in the year 2021. She has received grands three times from Tamilnadu state council for science and technology for her research proposal and completed successfully.

Abdeen Mustafa Omer (BSc, MSc, PhD) is an Associate Researcher at Energy Research Institute (ERI). He obtained both his PhD degree in the Built Environment and Master of Philosophy degree in Renewable Energy Technologies from the University of Nottingham. He is a qualified Mechanical Engineer with a proven track record within the water industry and renewable energy technologies. He has been graduated from the University of El Menoufia, Egypt, BSc in Mechanical Engineering. His previous experience involved being a member of the research team at the National Council for Research/Energy Research Institute in Sudan and working director of research and development for National Water Equipment Manufacturing Co. Ltd., Sudan. He has been listed in the book WHO’S WHO in the World 2005, 2006, 2007 and 2010. He has published over 300 papers in peer-reviewed journals, 200 review articles, 7 books and 150 chapters in books.